DE69925371D1 - Impfstoff für geflügel - Google Patents

Impfstoff für geflügel

Info

Publication number
DE69925371D1
DE69925371D1 DE69925371T DE69925371T DE69925371D1 DE 69925371 D1 DE69925371 D1 DE 69925371D1 DE 69925371 T DE69925371 T DE 69925371T DE 69925371 T DE69925371 T DE 69925371T DE 69925371 D1 DE69925371 D1 DE 69925371D1
Authority
DE
Germany
Prior art keywords
poultry
vaccinate
protein
delivering
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69925371T
Other languages
English (en)
Other versions
DE69925371T2 (de
Inventor
M Aehle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celldex Therapeutics Inc
Original Assignee
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc
Application granted granted Critical
Publication of DE69925371D1 publication Critical patent/DE69925371D1/de
Publication of DE69925371T2 publication Critical patent/DE69925371T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
DE69925371T 1998-07-24 1999-07-13 Impfstoff für geflügel Expired - Fee Related DE69925371T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/122,299 US6713073B1 (en) 1998-07-24 1998-07-24 Method of vaccination of newly hatched poultry
US122299 1998-07-24
PCT/US1999/015843 WO2000004920A2 (en) 1998-07-24 1999-07-13 Method of vaccination of newly hatched poultry

Publications (2)

Publication Number Publication Date
DE69925371D1 true DE69925371D1 (de) 2005-06-23
DE69925371T2 DE69925371T2 (de) 2006-01-19

Family

ID=22401889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925371T Expired - Fee Related DE69925371T2 (de) 1998-07-24 1999-07-13 Impfstoff für geflügel

Country Status (12)

Country Link
US (4) US6713073B1 (de)
EP (1) EP1100461B1 (de)
JP (1) JP2003529529A (de)
CN (1) CN100346825C (de)
AT (1) ATE295720T1 (de)
AU (1) AU4991599A (de)
BR (1) BR9912409A (de)
CA (1) CA2338551C (de)
DE (1) DE69925371T2 (de)
ES (1) ES2243064T3 (de)
MX (1) MXPA01000885A (de)
WO (1) WO2000004920A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
EP1319410A1 (de) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Verwendung von Mikroorganismen zur gezielten Verabreichung von Mitteln in specifischen Teilen des Darms
US8133493B2 (en) 2002-04-15 2012-03-13 Washington University Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
US8393294B2 (en) * 2004-06-02 2013-03-12 James B. Watson Live bacteria liquid product applicator and remote management system therefore
US7741109B2 (en) * 2004-06-02 2010-06-22 Watson James B Method for applying live bacteria liquid product
BRPI0511843A (pt) 2004-06-07 2008-01-15 Intervet Int Bv dispositivo para distribuir uma composição biologicamente ativa, uso do mesmo, placa kit, e, método para preparar gotìculas
BRPI0615593A2 (pt) * 2005-08-30 2011-05-24 Commw Scient And Ind Reseaech Organisation liberação bacteriana de polipeptìdeos biologicamente ativos
WO2007106073A2 (en) 2006-03-02 2007-09-20 University Of Massachusetts Modified pathogens for use as vaccines
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
EP2829281B1 (de) * 2012-03-22 2019-01-16 KM Biologics Co., Ltd. Lps-impfstoff
US9730991B2 (en) * 2012-09-06 2017-08-15 Eveliqure Biotechnologies Gmbh Live attenuated Shigella vaccine
ES2753369T3 (es) * 2013-04-05 2020-04-08 Univ Alberta Vacuna de Campylobacter
US10350041B2 (en) 2013-11-25 2019-07-16 Zoetis Services Llc Vaccination system for delivering vaccine to avian pullets, and associated methods, devices, and assemblies
US9763428B2 (en) 2013-11-25 2017-09-19 Zoetis Services Llc Holder apparatus for avian birds, and associated method
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
JP6605042B2 (ja) * 2015-12-07 2019-11-13 ザイマージェン インコーポレイテッド Ｈｔｐゲノム操作プラットフォームによる微生物株の改良
CN106125831B (zh) * 2016-06-17 2019-04-23 联想(北京)有限公司 旋转结构及电子设备
RU2692925C1 (ru) * 2018-12-07 2019-06-28 Константин Вячеславович Корсаков Способ увеличения продуктивности и выживаемости птицы

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US4316464A (en) 1981-03-09 1982-02-23 Select Laboratories, Inc. Poultry vaccination system
US4449968A (en) * 1981-03-09 1984-05-22 Select Laboratories, Inc. Poultry vaccination system
US4888170A (en) 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
EP0213753B1 (de) * 1985-08-01 1990-09-19 Harry Frankel Gerät zur Zerstäubungsvakzination
US5387744A (en) 1987-06-04 1995-02-07 Washington University Avirulent microbes and uses therefor: Salmonella typhi
US5294441A (en) * 1987-06-04 1994-03-15 Washington University Avirulent microbes and uses therefor: salmonella typhi
US5468485A (en) 1987-06-04 1995-11-21 Washington University Avirulent microbes and uses therefor
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
AU637969B2 (en) 1987-10-07 1993-06-17 Washington University A method of maintaining a desired recombinant gene in a genetic population of cells
JP2849632B2 (ja) 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
ES2090129T3 (es) 1989-03-31 1996-10-16 Univ Washington Vacunas que contienen microorganismos tipo phop avirulentos.
EP0465561A4 (en) * 1989-03-31 1992-04-08 Washington University Avirulent microbes and uses therefor
US5312353A (en) 1993-03-24 1994-05-17 Boggess Gregory D Modular poultry automatic vaccine injection and spray apparatus
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry

Also Published As

Publication number Publication date
EP1100461A2 (de) 2001-05-23
DE69925371T2 (de) 2006-01-19
ES2243064T3 (es) 2005-11-16
AU4991599A (en) 2000-02-14
EP1100461B1 (de) 2005-05-18
CN100346825C (zh) 2007-11-07
WO2000004920A3 (en) 2000-04-27
US20040170639A1 (en) 2004-09-02
US20040180062A1 (en) 2004-09-16
CA2338551C (en) 2007-10-02
MXPA01000885A (es) 2002-06-04
WO2000004920A2 (en) 2000-02-03
US6713073B1 (en) 2004-03-30
CA2338551A1 (en) 2000-02-03
ATE295720T1 (de) 2005-06-15
US6866847B1 (en) 2005-03-15
CN1314809A (zh) 2001-09-26
BR9912409A (pt) 2001-12-11
JP2003529529A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
DE69925371D1 (de) Impfstoff für geflügel
BR9713463A (pt) Fitase de bacillus subtilis, gene codificando a referida fitase, método para a produção e uso da mesma
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ATE399177T1 (de) Derivate therapeutischer peptide
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
BR9811094A (pt) Agente terapêutico para tumores linfáticos
ATE273997T1 (de) Zyklische hexapeptid somatostatin analoga
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ES8303440A1 (es) "procedimiento para la preparacion de acidos oxazafosforin-4-tio-alcansulfonicos".
PT1267915E (pt) Metodos para tratar doencas com proteina c activada
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
MXPA02009781A (es) Isoformas de esfingosina cinasa tipo 2 de mamifero, clonacion, expresion y metodos de uso de las mismas.
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
EP1282641A4 (de) MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
GB9604518D0 (en) Novel compounds
ES2191785T3 (es) Proteina de accion antitumoral.
EP1467207A4 (de) Screening-verfahren
ID28859A (id) Proses untuk meningkatkan produksi telur dan memperkuat kulit telur unggas
ATE69240T1 (de) Mitogene peptide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee